Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Anesiva Files NDA For Zingo Topical Anesthetic

This article was originally published in The Pink Sheet Daily

Executive Summary

Firm is initially seeking a pediatric indication for needle-free system but plans to expand label to include adults following completion of Phase III trial.

You may also be interested in...



Anesiva’s Fast-Acting Analgesic Zingo Clears FDA Ahead Of User Fee Date

The company is seeking a U.S. partner to aid in the launch of its first drug, CEO says.

Anesiva’s Fast-Acting Analgesic Zingo Clears FDA Ahead Of User Fee Date

The company is seeking a U.S. partner to aid in the launch of its first drug, CEO says.

Pharmos’ Synthetic Cannabinoid Disappoints In Phase IIa

Company will study oral cannabinor for neuropathic pain, adjust intravenous dosing for nociceptive pain.

Topics

UsernamePublicRestriction

Register

LL111109

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel